Literature DB >> 32005681

Erratum for Research Article "Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis" by C. Carmona-Rivera, P. M. Carlucci, E. Moore, N. Lingampalli, H. Uchtenhagen, E. James, Y. Liu, K. L. Bicker, H. Wahamma, V. Hoffman, A. I. Catrina, P. Thompson, J. H. Buckner, W. H. Robinson, D. A. Fox, M. J. Kaplan.

.   

Abstract

Entities:  

Year:  2020        PMID: 32005681      PMCID: PMC7228189          DOI: 10.1126/sciimmunol.aaz9319

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


× No keyword cloud information.
  4 in total

1.  Technical comment on "Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis".

Authors:  A J Salinger; M L Dubuke; C Carmona-Rivera; A J Maurais; S A Shaffer; E Weerapana; P R Thompson; M J Kaplan
Journal:  Sci Immunol       Date:  2020-01-31

2.  Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.

Authors:  Niña G Caculitan; Josefa Dela Cruz Chuh; Yong Ma; Donglu Zhang; Katherine R Kozak; Yichin Liu; Thomas H Pillow; Jack Sadowsky; Tommy K Cheung; Qui Phung; Benjamin Haley; Byoung-Chul Lee; Robert W Akita; Mark X Sliwkowski; Andrew G Polson
Journal:  Cancer Res       Date:  2017-10-18       Impact factor: 12.701

3.  Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis.

Authors:  Carmelo Carmona-Rivera; Philip M Carlucci; Erica Moore; Nithya Lingampalli; Hannes Uchtenhagen; Eddie James; Yudong Liu; Kevin L Bicker; Heidi Wahamaa; Victoria Hoffmann; Anca Irinel Catrina; PaulR Thompson; Jane H Buckner; William H Robinson; David A Fox; Mariana J Kaplan
Journal:  Sci Immunol       Date:  2017-04-14

4.  Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice.

Authors:  Yasuaki Anami; Chisato M Yamazaki; Wei Xiong; Xun Gui; Ningyan Zhang; Zhiqiang An; Kyoji Tsuchikama
Journal:  Nat Commun       Date:  2018-06-28       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.